You just read:

Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease

News provided by

Bayer HealthCare Pharmaceuticals

Nov 30, 2009, 09:00 ET